DNA vaccine may let hepatitis b patients ditch daily pills
NCT ID NCT00536627
First seen Apr 16, 2026 · Last updated May 14, 2026 · Updated 3 times
Summary
This study tested a DNA vaccine in 70 adults with chronic hepatitis B who had undetectable virus levels from antiviral drugs. The goal was to see if the vaccine could train the immune system to keep the virus under control after stopping medication. Researchers measured how long it took for the virus to return and checked for side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
FONTAINE Hélène
Paris, France
Conditions
Explore the condition pages connected to this study.